Han B - Search Results

1

New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer.

Qiang H, Chang Q, Xu J, Qian J, Zhang Y, Lei Y, Han B, Chu T. Qiang H, et al. Among authors: han b. J Cancer Res Clin Oncol. 2020 Mar;146(3):631-645. doi: 10.1007/s00432-020-03129-6. Epub 2020 Feb 17. J Cancer Res Clin Oncol. 2020. PMID: 32065262 Review.

2

[The relationship between drug sensitivity and expression of drug resistance gene mutations in non-small cell lung cancer].

Han B, Liao M, Su J, Feng J, Wang E, Dong Q. Han B, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2002 Dec;25(12):727-31. Zhonghua Jie He He Hu Xi Za Zhi. 2002. PMID: 12622891 Chinese.

3

[Vascular endothelial growth factor inhibits dendritic cells from patients with non-small cell lung carcinoma].

Fan XH, Han BH, Dong QG, Sha HF, Bao GL, Liao ML. Fan XH, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2003 Sep;26(9):539-43. Zhonghua Jie He He Hu Xi Za Zhi. 2003. PMID: 14521757 Chinese.

4

[Implication of micrometastatic cancer cells in the peripheral blood on prognosis of non-small cell lung cancer].

Huang JS, Dong QG, Bao GL, Han BH. Huang JS, et al. Zhonghua Zhong Liu Za Zhi. 2004 May;26(5):294-6. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15312367 Chinese.

5

Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth.

Zhong H, Han B, Tourkova IL, Lokshin A, Rosenbloom A, Shurin MR, Shurin GV. Zhong H, et al. Among authors: han b. Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5455-62. doi: 10.1158/1078-0432.CCR-07-0517. Clin Cancer Res. 2007. PMID: 17875775 Free PMC article.

6

[Randomized study of thalidomide combined with vinorelbine and cisplatin chemotherapy for the treatment of advanced non-small cell lung cancer].

Gu AQ, Han BH, Zhang XY, Shen J, Qi DJ, Xiong LW, Xin Y, Song YY. Gu AQ, et al. Zhonghua Zhong Liu Za Zhi. 2009 Apr;31(4):298-301. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615288 Clinical Trial. Chinese.

7

[Clinical observation of gefitinib for the treatment of 125 cases with advanced non-small cell lung cancer].

Gu AQ, Wang HM, Shi CL, Xiong LW, Gao ZQ, Han BH. Gu AQ, et al. Zhonghua Zhong Liu Za Zhi. 2010 Jan;32(1):71-4. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20211075 Clinical Trial. Chinese.

8

Prognostic significance of OCT4 expression in adenocarcinoma of the lung.

Zhang X, Han B, Huang J, Zheng B, Geng Q, Aziz F, Dong Q. Zhang X, et al. Among authors: han b. Jpn J Clin Oncol. 2010 Oct;40(10):961-6. doi: 10.1093/jjco/hyq066. Epub 2010 May 12. Jpn J Clin Oncol. 2010. PMID: 20462980

9

[Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer].

Gao ZQ, Han BH, Sha HF, Shi ZY, Yang XH, Feng JX. Gao ZQ, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2010 Apr;33(4):284-8. Zhonghua Jie He He Hu Xi Za Zhi. 2010. PMID: 20646461 Chinese.

10

A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.

Shi CL, Zhang XY, Han BH, He WZ, Shen J, Chu TQ. Shi CL, et al. Med Oncol. 2011 Dec;28(4):1441-6. doi: 10.1007/s12032-010-9632-y. Epub 2010 Jul 27. Med Oncol. 2011. PMID: 20661664

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,035 results

Search Page

Filters